U.S. market Open. Closes in 3 hours 18 minutes

ALNY | Alnylam Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
Revenue1.83B1.04B844.29M492.85M219.75M74.91M89.91M47.16M41.10M50.56M47.17M66.72M82.76M100.04M100.53M96.16M50.90M26.93M5.72M4.28M176.00KN/A
Cost of Revenue310.41M168.82M140.14M78.05M25.06M1.80M13.37MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit1.52B868.60M704.14M414.80M194.69M73.11M76.55M47.16M41.10M50.56M47.17M66.72M82.76M100.04M100.53M96.16M50.90M26.93M5.72M4.28M176.00KN/A
Operating Expenses1.80B1.65B1.41B1.24B1.13B887.78M590.00M471.75M337.11M234.78M140.11M131.18M137.57M144.11M148.64M124.00M144.07M66.43M49.19M36.54M20.62M4.22M
Selling, General & Admin795.65M770.66M620.64M588.42M479.00M382.36M199.37M89.35M60.61M44.53M27.15M44.61M38.28M37.73M39.91M27.11M23.39M16.63M13.87M11.94M7.53M880.00K
Research & Development1.00B883.01M792.16M654.82M655.11M505.42M390.63M382.39M276.50M190.25M112.96M86.57M99.30M106.38M108.73M96.88M120.69M49.80M35.32M24.60M13.10M3.34M
Other Operating ExpensesN/A-109.37M-2.05M45.52M20.73M4.17M-3.02M6.17M76.00K1.82M-47.00K331.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-282.18M-785.07M-708.65M-828.44M-939.43M-814.67M-500.09M-424.59M-296.01M-404.98M-92.94M-129.46M-54.82M-44.07M-48.11M-27.84M-93.18M-39.50M-43.47M-32.26M-25.06M-4.22M
Other Expenses / Income-151.34M-341.92M-143.49M-27.16M54.18M54.00M9.21M14.48M5.93M4.38M1.02M12.87M-2.83M1.07M1.10M2.31M12.96M4.89M558.00K-390.00K-4.64MN/A
Before Tax Income-433.52M-1.13B-852.14M-855.60M-885.25M-760.67M-490.87M-410.11M-290.07M-400.60M-91.92M-116.59M-57.65M-43.00M-47.01M-25.53M-80.22M-34.61M-42.91M-35.37M-29.69MN/A
Income Tax Expenses6.72M4.16M680.00K2.68M863.00K823.00K-25.60M-23.44M-24.91M-40.21M-2.69M-10.57M-5.80M514.00K582.00K719.00K5.25M-4.89M-558.00K390.00K4.58M-86.00K
Net Income-440.24M-1.13B-852.82M-858.28M-886.12M-761.50M-490.87M-410.11M-290.07M-360.39M-89.22M-106.01M-57.65M-43.52M-47.59M-26.25M-85.47M-34.61M-42.91M-32.65M-25.03M-4.14M
Interest Expenses121.22M155.97M143.02M84.50MN/A29.26M12.24M8.31M5.86M2.56M1.07M977.00K1.21M2.31M5.38M872.00K1.08MN/AN/AN/AN/AN/A
Basic Shares Outstanding124.91M121.69M118.45M114.99M109.26M100.59M90.55M85.60M83.99M74.28M61.55M50.29M42.41M42.04M41.63M41.08M38.66M31.89M21.95M11.89M942.66K331.34K
Diluted Shares Outstanding124.91M121.69M118.45M114.99M109.26M100.59M90.55M85.60M83.99M74.28M61.55M50.29M42.41M42.04M41.63M41.08M38.66M31.89M21.95M11.89M942.66K331.34K
EBITDA-258.24M-926.56M-661.56M-736.33M-868.08M-754.24M-488.19M-409.46M-276.96M-172.29M-82.71M-51.71M-49.69M-38.06M-41.02M-18.93M-75.06M-35.69M-38.83M-29.55M-19.61M-4.19M
EBITDA Margin-14.12%-89.31%-78.36%-149.40%-395.03%-1,006.89%-542.96%-868.25%-673.91%-340.75%-175.36%-77.50%-60.05%-38.04%-40.80%-19.69%-147.47%-132.51%-679.25%-690.72%-11,142.05%0.00%
EBIT-312.30M-971.02M-709.12M-771.10M-885.25M-731.41M-504.24M-425.24M-309.12M-398.05M-90.85M-115.61M-62.24M-40.70M-41.62M-24.66M-79.14M-39.50M-43.47M-32.26M-20.45M-4.22M
EBIT Margin-17.08%-93.60%-83.99%-156.46%-402.85%-976.41%-560.82%-901.71%-752.18%-787.26%-192.62%-173.26%-75.21%-40.68%-41.40%-25.64%-155.49%-146.68%-760.53%-754.18%-11,618.18%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙